Verano Holdings Corp

General ticker "VRNOF" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $473.6M

Verano Holdings Corp does not follow the US Stock Market performance with the rate: -38.1%.

Estimated limits based on current volatility of 4.5%: low 1.18$, high 1.29$

Factors to consider:

  • Company does not operate outside North America (retrieved using AI)
  • Current price 44.9% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.27$, 4.80$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.39$, 4.97$]

Financial Metrics affecting the VRNOF estimates:

  • Negative: Non-GAAP EPS, $ of -0.17 <= 0.10
  • Negative: negative Net income
  • Positive: -0.96 < Investing cash flow per share, $ of -0.14
  • Positive: 1.03 < Operating profit margin, % of 9.03
  • Negative: Industry earnings per price (median), % of -15.01 <= 1.31
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85

Similar symbols

Short-term VRNOF quotes

Long-term VRNOF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31
Operating Revenue $879.41MM $938.45MM
Operating Expenses $1,040.54MM $853.67MM
Operating Income $-161.13MM $84.78MM
Non-Operating Income $-2.27MM $-56.99MM
Interest Expense $49.43MM $59.79MM
R&D Expense $1.17MM $0.00MM
Income(Loss) $-163.40MM $27.80MM
Taxes $105.47MM $145.15MM
Profit(Loss) $-268.87MM $-117.35MM
Stockholders Equity $1,341.55MM $1,240.08MM
Inventory $164.53MM $140.69MM
Assets $2,396.05MM $2,318.74MM
Operating Cash Flow $94.35MM $109.71MM
Capital expenditure $119.17MM $36.33MM
Investing Cash Flow $-207.85MM $-47.40MM
Financing Cash Flow $99.25MM $27.60MM
Earnings Per Share* $-0.81 $-0.34

* EPS are Split Adjusted, recent splits may be reflected with a delay.